BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R.10571: SURGE TO SAVE NEWBORNS ACT; PROVISIONS RELATED TO NEWBORN SCREENING GENERAL DISCUSSIONS REGARDING ORPHAN DRUGS GENERAL DISCUSSIONS REGARDING GENETIC SCREENING AND TESTING
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL MAYNE | — |
Medicare/Medicaid MMM
GENERAL DISCUSSIONS RELATED TO MOST-FAVORED-NATION (MFN) FOREIGN REFERENCE PRICING GENERAL DISCUSSIONS REGARDING UTILIZATION MANAGEMENT
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL MAYNE | — |
Tariff (miscellaneous tariff bills) TAR
GENERAL DISCUSSIONS REGARDING TARIFFS
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL MAYNE | — |
Medical/Disease Research/Clinical Labs MED
H.R.10359: PRIORITY FOR PEDIATRIC CURES ACT; PROVISIONS RELATED TO REMOVAL OF RARE PEDIATRIC PRIORITY REVIEW VOUCHERS SUNSET GENERAL DISCUSSIONS REGARDING CLINICAL TRIALS
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL MAYNE | — |
Taxation/Internal Revenue Code TAX
H.R. 1414: CAMERON'S LAW; ALL PROVISIONS
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL MAYNE | — |
Copyright/Patent/Trademark CPT
DISCUSSIONS REGARDING INTELLECTUAL PROPERTY AND U.S. INTERNATIONAL TRADE COMMISSION EXCLUSION ORDER
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL MAYNE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.